As trials get underway in Brazil, Peter Hotez and his colleagues are hoping their vaccine will put an end to a parasite's evasive immune maneuvers - and its devastating morbidity.
The article you are attempting to read is Premium content which is only available to our online subscribers.
Subscribing to The Scientist is easy and inexpensive.
And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.
The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today